Trials / Completed
CompletedNCT01569737
Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
Prospective Multicenter Observational Study to Assess Clinical Follow-up and Outcomes of Pregnancies Exposed to Ella
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 98 (actual)
- Sponsor
- HRA Pharma · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study is aimed at assessing the clinical follow-up and the outcomes of pregnancies exposed to ella, whether due to failure of the emergency contraception or inadvertent exposure during pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ella | ella, single intake, tablet 30mg |
Timeline
- Start date
- 2014-11-18
- Primary completion
- 2018-06-29
- Completion
- 2018-06-29
- First posted
- 2012-04-03
- Last updated
- 2019-10-21
- Results posted
- 2019-10-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01569737. Inclusion in this directory is not an endorsement.